In every ones opinion. Say we're at $10 and then get approved, what do you think? Bump to $15 overnight. I know they deny and back to sub-penny most likely.
I also know a lot of factors will have to be considered. Do we have a partner, Is the data for PFS good or great.
I think if data for PFS is great we will partner for distribution prior to FDA and the price will reflect clost to after approval price due to the fact the writing is on the wall.
If data is not so great for PFS we get a bump in price a few bucks and no partner till after FDA's decision and it could go either way.
Much greater gamble on second scenario. Just board and thinking out loud.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.